Blueprint Medicines所有資訊

Blueprint Medicines | 144：擬議出售證券

11/07 17:33 (美東)

Blueprint Medicines | 10-Q：2024財年三季報

10/30 16:32 (美東)

Blueprint Medicines | 8-K：Blueprint Medicinib 公佈2024年第三季度業績並上調了AYVAKIT® /AyvaKYT®（avapritinib）全年收入指引

10/30 07:11 (美東)

Blueprint Medicines | 4：持股變動聲明-高管 Namouni Fouad

10/04 17:14 (美東)

Blueprint Medicines | 4：持股變動聲明-董事 Albers Jeffrey W.

09/11 16:11 (美東)

Blueprint Medicines | 144：擬議出售證券

09/09 21:26 (美東)

Blueprint Medicines | 4：持股變動聲明-高管 Landsittel Michael

08/19 16:03 (美東)

Blueprint Medicines | 144：擬議出售證券

08/15 16:32 (美東)

Blueprint Medicines | 4：持股變動聲明-高管 Lee Philina

08/07 17:12 (美東)

Blueprint Medicines | 144：擬議出售證券

08/05 16:53 (美東)

Blueprint Medicines | 10-Q：2024財年二季報

08/01 16:52 (美東)

Blueprint Medicines | 8-K：Blueprint Medicinib 公佈2024年第二季度業績並上調了AYVAKIT® /AYVAKYT®（avapritinib）全年收入指引

08/01 07:31 (美東)

Blueprint Medicines | 4：持股變動聲明-高管 Carter Percy H.

07/08 19:13 (美東)

Blueprint Medicines | 4：持股變動聲明-高管 Rossi Christina

07/08 19:13 (美東)

Blueprint Medicines | 4：持股變動聲明-高管 Durso-Bumpus Debra

07/08 16:08 (美東)

Blueprint Medicines | 4：持股變動聲明-高管 Durso-Bumpus Debra

07/02 16:10 (美東)

Blueprint Medicines | 4：持股變動聲明-高管 Durso-Bumpus Debra

06/25 16:01 (美東)

Blueprint Medicines | 144：擬議出售證券

06/21 17:56 (美東)

Blueprint Medicines | S-8：員工福利計劃證券登記

06/21 16:41 (美東)

Blueprint Medicines | 4：持股變動聲明-董事 Albers Jeffrey W.

06/14 17:45 (美東)